参考文献
［1］王吉耀,廖二元,黄从新,等.内科学[M].北京:人民卫生出版社, 2010: 175-273.
［2］顾景范.《中国居民营养与慢性病状况报告(2015)》解读[J].营养学报, 2016 (6).
［3］李伟,于水,孙扬,等.《国际功能、残疾和健康分类·髋痛与活动度不足-髋骨关节炎: 2017修订版》临床实践指南[J].康复学报, 2019, 29 (02): 1-19.
［4］种晓艺,张小田等,肥胖对肿瘤患者治疗和临床结局的影响[J].肿瘤代谢与营养电子杂志, 2019, 6 (2): 172-177.
［5］王霞,宗慧敏,刘春蓓,等.肥胖相关性肾病的远期预后及危险因素分析[J].肾脏病与透析肾移植杂志, 2018, 27 (06): 507-512.
［6］ HINNOUHO GM, CZERNICHOW S, DUGRAVOT A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type2 diabetes: the Whitehall II cohort study [J]. Eur Heart J, 2015, 36 (9): 551-559.
［7］ WHITAKER BN, FISHER PL, JAMBHEKAR S, et al. Impact of degree of obesity on sleep, quality of life, and depression in youth [J]. J Pediatr Health Care, 2018, 32 (2): e37-e44.
［8］LIU T Z, XU C, ROTA M, et al. Sleep duration and risk of allcause mortality: a fl exible, nonlinear, meta-regression of 40prospective cohort studies [J]. Sleep Med Rev, 2017(32): 28-36.DOI: 10. 1016/j. smrv. 2016. 02. 005.
［9］ITANI O, JIKE M, WATANABE N, et al. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression [J]. Sleep Med, 2016(pii): S1389-9457 (16) 30138-1. DOI: 10. 1016/j. sleep. 2016. 08. 006.
［10］JENSEN MD, RYAN DH, APOVIAN CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J]. J Am Coll Cardiol, 2014, 63 (25): 2985-3023. DOI: 10. 1016/j. jacc. 2013. 11. 004.
［11］ VINA ER, AND KWOH CK. Epidemiology of Osteoarthritis: Literature Update [J]. Curr Opin Rheumatol, 2018, 30 (2): 160-167.
［12］ GLENN T, HARRIS AL, LINDHEIM SR. Impact of obesity on male and female reproductive outcomes [J]. Curr Opin Obstet Gynecol, 2019, 31 (4): 201-206.
［13］ LANDSBERG L, ARONNE LJ, BEILIN LJ, et al. Obesity-related ypertension: pathogenesis, cardiovascularrisk, andtreatment: a position paper of The Obesity Society and the American Society of Hypertension [J]. J Clin Hypertens (Grenwich), 2013, 15 (1): 14-33.
［14］BHASKARAN K, DOUGLAS I, FORBES H, et al. Body-mass index and risk of 22 specif i c cancers: A population-based cohort study of 5. 24 million UK adults [J]. Lancet, 2014, 384(9945): 755-765.
［15］ GASIOR-PERCZAK D, PALYGA I, SZYMONEK M, et al. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer [J]. PLo S One, 2018, 13 (10): e204668.
［16］ CHUNG YS, LEE JH, LEE YD. Is body mass index relevant to prognosis of papillary thyroid carcinoma?A clinicopathological cohort study [J]. Surg Today, 2017,47 (4): 506-512.
［17］ WU C, WANG L, CHEN W, et al. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study [J]. Medicine (Baltimore), 2017, 96 (9): e6202.
［18］ LAUBY-SECRETAN B, SCOCCIANTI C, LOOMIS D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group [J]. N Engl J Med, 2016 (375): 794-798.
［19］ SCIACCA L, VIGNERI R, TUMMINIA A, et al. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients [J]. Nutr. Metab. Cardiov. Dis,2013 (23): 808-815.
［20］ GUO S. Insulin signaling, resistance, and the metabolic syndrome: insights frommouse modelstodiseasemechanisms [J]. J Endocrinol, 2014, 220 (2): T1-T23.
［21］ LIU CR, LI Q, HOU C, et al. Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk [J]. DNA Cell Biol, 2018, 37 (3): 182-188.
［22］ PIYA MK, MCTERNAN PG, KUMAR S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin [J]. Journal of Endocrinology,2013 (216): T1-T15.
［23］ CASTRO AV, KOLKA CM, KIM SP, et al. Obesity, insulin resistance and comorbidities-Mechanisms of association. Arq Bras Endocrinol Metabol, 2014, 58 (6): 600-609.